# Clinical utility of evoked potentials for programming subthalamic deep brain stimulation in Parkinsons disease

**Authors:** Blake Hale, Anna Latorre, Lorenzo Rocchi, John Rothwell, Patricia Limousin

PMC · DOI: 10.1038/s41531-026-01274-2 · NPJ Parkinson's Disease · 2026-01-23

## TL;DR

This paper reviews how evoked potentials can help improve deep brain stimulation programming for Parkinson's disease.

## Contribution

The paper evaluates evoked potentials as potential biomarkers for optimizing subthalamic deep brain stimulation programming.

## Key findings

- Evoked potentials may provide objective evidence for STN-DBS programming.
- Literature suggests potential clinical utility of evoked potentials in reducing side effects.
- Integration of electrophysiological data could streamline STN-DBS adjustments.

## Abstract

Optimal subthalamic nucleus deep-brain stimulation (STN-DBS) for Parkinson’s disease reduces motor symptoms without stimulating adjacent structures and causing side-effects. Fine-tuning STN-DBS using clinical evaluation is time-consuming and often requires multiple follow-ups. Electrophysiological recordings may enhance STN-DBS device programming for clinicians by providing objective evidence of neural pathway activation. This literature review critically evaluates evoked potentials as biomarkers of optimal STN-DBS and assesses potential integration into the device programming toolkit.

## Linked entities

- **Diseases:** Parkinson’s disease (MONDO:0005180)

## Full-text entities

- **Diseases:** Parkinson's disease (MESH:D010300)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12929793/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12929793/full.md

## References

14 references — full list in the complete paper: https://tomesphere.com/paper/PMC12929793/full.md

---
Source: https://tomesphere.com/paper/PMC12929793